文献速递胸部肿瘤

恶性胸膜间皮瘤微环境的潜在诊断与预后价值

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.
PubMed 文献 · J Thorac Oncol · 2019-05-09

研究纳入275例初诊胸腔积液患者,用多参数流式细胞术盲法检测胸水与胸膜活检标本的免疫表型。肿瘤内调节性T细胞、M2巨噬细胞、髓源性抑制细胞及CD4+/CD8+PD-1+、LAG-3+、TIM-3+细胞各阈值可区分恶性胸膜间皮瘤与胸膜炎,灵敏度100%、特异度89%;胸水免疫表型无预后意义,而肿瘤内调节性T细胞与髓源性抑制细胞水平与无进展生存和总生存显著相关。

要点

  • 肿瘤内调节性T细胞>1.1%、M2巨噬细胞>36%、粒细胞系与单核细胞系髓源性抑制细胞分别>5.1%和4.2%等阈值组合区分恶性胸膜间皮瘤与胸膜炎的灵敏度为100%、特异度为89%。
  • 肿瘤内髓源性抑制细胞的存在促进肿瘤浸润淋巴细胞无能。
  • 胸水细胞免疫表型无预后意义;肿瘤内调节性T细胞与髓源性抑制细胞水平与无进展生存和总生存显著相关,PD-1+/LAG-3+/TIM-3+ CD4+肿瘤浸润淋巴细胞与总生存相关。

核心结论

  • 恶性胸膜间皮瘤患者胸水与组织的明确免疫特征可能有助于更好地预测患者结局。

研究设计与样本

  • 研究纳入275例初诊临床诊断为胸腔积液的患者,对用于病理诊断和免疫表型分析的胸水标本与胸膜活检样本进行盲法多参数流式细胞术检测。
  • 结果采用Kruskal-Wallis检验分析,Kaplan-Meier与log-rank检验用于将免疫表型数据与患者结局相关联。

主要发现

  • 肿瘤内调节性T细胞>1.1%、M2巨噬细胞>36%、粒细胞系髓源性抑制细胞>5.1%与单核细胞系髓源性抑制细胞>4.2%、CD4+PD-1+>5.2%与CD8+PD-1+6.4%、CD4+LAG-3+>2.8%与CD8+LAG-3+>2.8%、CD4+TIM-3+>2.5%与CD8+TIM-3+>2.6%的阈值可将恶性胸膜间皮瘤与胸膜炎区分,灵敏度100%、特异度89%。
  • 肿瘤内髓源性抑制细胞的存在促进肿瘤浸润淋巴细胞无能。
  • 胸水细胞免疫表型无预后意义;肿瘤内调节性T细胞与髓源性抑制细胞水平与无进展生存和总生存显著相关,PD-1+/LAG-3+/TIM-3+ CD4+肿瘤浸润淋巴细胞与总生存相关。

关键数值与推荐

  • 肿瘤内调节性T细胞>1.1%、M2巨噬细胞>36%、粒细胞系髓源性抑制细胞>5.1%、单核细胞系髓源性抑制细胞>4.2%。
  • CD4+PD-1+>5.2%、CD8+PD-1+6.4%、CD4+LAG-3+>2.8%、CD8+LAG-3+>2.8%、CD4+TIM-3+>2.5%、CD8+TIM-3+>2.6%。
  • 上述阈值组合区分恶性胸膜间皮瘤与胸膜炎的灵敏度100%、特异度89%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A comprehensive analysis of the immune cell infiltrate collected from pleural fluid and from biopsy specimens of malignant pleural mesothelioma (MPM) may contribute to understanding the immune-evasion mechanisms related to tumor progression, aiding in differential diagnosis and potential prognostic stratification. Until now such approach has not routinely been verified. METHODS: We enrolled 275 patients with an initial clinical diagnosis of pleural effusion. Specimens of pleural fluids and pleural biopsy samples used for the pathologic diagnosis and the immune phenotype analyses were blindly investigated by multiparametric flow cytometry. The results were analyzed using the Kruskal-Wallis test. The Kaplan-Meier and log-rank tests were used to correlate immune phenotype data with patients' outcome. RESULTS: The cutoffs of intratumor T-regulatory (>1.1%) cells, M2-macrophages (>36%), granulocytic and monocytic myeloid-derived suppressor cells (MDSC; >5.1% and 4.2%, respectively), CD4 molecule-positive (CD4+) programmed death 1-positive (PD-1+) (>5.2%) and CD8+PD-1+ (6.4%) cells, CD4+ lymphocyte activating 3-positive (LAG-3+) (>2.8% ) and CD8+LAG-3+ (>2.8%) cells, CD4+ T cell immunoglobulin and mucin domain 3-positive (TIM-3+) (>2.5%), and CD8+TIM-3+ (>2.6%) cells discriminated MPM from pleuritis with 100% sensitivity and 89% specificity. The presence of intratumor MDSC contributed to the anergy of tumor-infiltrating lymphocytes. The immune phenotype of pleural fluid cells had no prognostic significance. By contrast, the intratumor T-regulatory and MDSC levels significantly correlated with progression-free and overall survival, the PD-1+/LAG-3+/TIM-3+ CD4+ tumor-infiltrating lymphocytes correlated with overall survival. CONCLUSIONS: A clear immune signature of pleural fluids and tissues of MPM patients may contribute to better predict patients' outcome.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Salaroglio IC, Kopecka J, Napoli F, et al. Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. J Thorac Oncol. 2019. PMID: 31078776. doi:10.1016/j.jtho.2019.03.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。